Best Infertility Doctors In India

India is in the middle of a quiet fertility crisis that does not always look like one. Couples are starting families later, PCOS is now estimated to affect one in five Indian women of reproductive age, obesity rates in urban populations are climbing, and sedentary desk-based work has become the dominant occupational pattern across the country's major cities. Each of these factors has a measurable effect on reproductive health. The fertility treatment infrastructure in India has grown considerably, but standard IVF and hormonal treatment addresses only part of this picture.

ICPRM operates in the space that standard fertility treatment does not reach. We investigate whether the immune system is the undocumented cause behind recurrent miscarriages, repeated IVF failure, and unexplained infertility. Couples across India can begin the process through an online consultation, making our evaluation accessible regardless of which city they are in. For couples who have been through the standard fertility cycle without resolution, the best infertility doctors in India at ICPRM offer a specific and evidence-based next step.

Causes Of Infertility In India

PCOS is the most widespread hormonal condition affecting fertility across Indian women, and its impact extends beyond ovulation. The insulin resistance associated with PCOS creates a systemic inflammatory environment that affects endometrial receptivity and immune cell function in ways that disrupt implantation. In cities, the sedentary lifestyle patterns that characterise IT and corporate employment compound this: reduced physical activity worsens insulin resistance, and chronic occupational stress alters the hormonal and immune landscape simultaneously. The cumulative effect is a fertility challenge that is broader than any single diagnostic label captures.

Delayed conception is a second national pattern with growing clinical significance. As the average age of first marriage and first pregnancy attempt continues to rise in urban India, the proportion of couples facing age-related fertility challenges increases accordingly. This is not about extreme maternal age. Even the shift from a first pregnancy attempt at 28 to one at 34 brings measurable changes in egg quality, hormonal reserve, and immune regulation.

The Role Of The Immune System In Infertility

Across the diverse fertility presentations that ICPRM sees from couples around India, one mechanism appears repeatedly: the immune system is not creating the environment a pregnancy needs. This can manifest differently depending on the underlying cause. In PCOS, it may be chronic endometrial inflammation. In delayed conception, subtle immune regulatory changes. In unexplained infertility, a specific failure of immune tolerance toward paternal antigens that leaves no fingerprint on standard investigations.

Lymphocyte immunotherapy corrects this at the source. ICPRM's ImmuLIT® procedure delivers prepared paternal lymphocytes to the mother before conception, stimulating a tolerance response that the immune system has not been generating independently. This is not a broad immunosuppressive intervention. It is a targeted biological signal, specific to the paternal antigens carried by the embryo, that prompts the immune system to shift from reactivity to protection. Research in reproductive immunology consistently supports this mechanism, and ICPRM's clinical outcomes, with approximately 80 percent success among confirmed immune cases, reflect its effectiveness when applied to appropriately selected patients.

Our Specialized Approach For Treating Infertility

Our national reach is built on an online-first consultation model that allows couples from any city in India to begin the evaluation process without travelling. Being the top infertility specialists in India, Dr Mugdha Raut and Dr Mohan Raut review the couple's complete fertility history, identify the pattern that suggests an immune mechanism, and then design an investigation plan that is specific to that pattern.

Where immune dysfunction is confirmed through investigation, ImmuLIT® is offered as the intervention. A single outpatient procedure taking approximately three hours, with no hospital admission, and a structured follow-up protocol that can be managed remotely for patients returning to their home cities. The procedure phase requires a visit to ICPRM's centre, which couples typically plan as a single trip once candidacy has been confirmed. The clinical efficiency of this model matters for a national patient base spread across diverse geographies.

The ImmuLIT® Treatment Process at ICPRM

For couples anywhere in India, the process follows a defined and medically grounded sequence from first contact to parenthood.

1. Online Consultation: A thorough virtual consultation reviews your complete fertility and pregnancy history, regardless of which city you are based in, before any investigation plan is recommended.
2. Investigations: A targeted reproductive immunology panel is recommended based on your specific history, covering the immune markers most relevant to your pattern of pregnancy failure or unexplained infertility.
3. Single-Sitting 3-Hour ImmuLIT® Procedure: Prepared paternal lymphocytes are administered to the mother in one three-hour outpatient sitting at ICPRM's centre, requiring no hospital admission or extended recovery period.
4. Follow-up: Post-procedure immune monitoring can be largely managed remotely, with the specialist tracking response markers and advising on the optimal timing for the next pregnancy attempt.
5. Parenthood: Couples across India who complete the process move forward toward pregnancy with a confirmed immune diagnosis, a specific treatment, and a clinical follow-up plan that supports the next attempt.

Why Patients Across India Choose ICPRM

For couples across India, the path to ICPRM usually runs through a history of standard fertility treatment that has not provided answers. The trusted infertility experts in India at ICPRM are not offering another round of the same approach. They are offering a specific investigation of the immune dimension of pregnancy failure, one that is grounded in decades of reproductive immunology research.

What differentiates ICPRM at a national level is the consistency of the clinical framework. Whether a couple comes from Mumbai, Delhi, Bengaluru, or a smaller city, they receive the same quality of immune investigation and the same access to ImmuLIT® if they are confirmed candidates. The treatment is not adapted by geography. The accessibility of the initial process is. That consistency, combined with a success rate of approximately 80 percent among confirmed immune-mediated cases, is what makes ICPRM a meaningful option for couples who have not found resolution through standard fertility care.

FAQs

1. Can couples from any city in India access ICPRM's care?

Yes. The online consultation and investigation review phases are accessible from anywhere in India. The ImmuLIT procedure itself requires a visit to ICPRM's centre, which most out-of-city patients complete in a single planned trip once they have been confirmed as appropriate candidates.

2. Is PCOS alone enough to cause the kind of pregnancy failures that ICPRM investigates?

PCOS can contribute to implantation difficulties through its effects on endometrial inflammation and insulin resistance. However, PCOS alone does not typically account for recurrent miscarriage or repeated IVF failure. When these patterns occur alongside PCOS, an immune evaluation is a clinically appropriate next step.

3. How is ICPRM different from a general fertility hospital that also offers immune support protocols?

General fertility hospitals that offer immune support typically apply it empirically, without a confirmed immune diagnosis. ICPRM investigates first to confirm that a specific immune mechanism is present, and then applies ImmuLIT as a targeted intervention based on those findings. The specificity of this sequence is what produces the 80 percent success rate ICPRM reports among appropriate candidates.

4. We are from a smaller city and cannot easily travel. How much of the ICPRM process can be done remotely?

The consultation and investigation review phases are conducted online. The investigation panel itself can often be completed at a diagnostic facility in your own city, with results reviewed remotely by ICPRM. Only the ImmuLIT procedure requires an in-person visit. The team helps coordinate this once candidacy is confirmed.

5. Does ICPRM work with both primary and secondary infertility cases?

Yes. ICPRM evaluates immune-mediated causes in both primary infertility, where no previous pregnancy has occurred, and secondary infertility, where a previous pregnancy was successful but subsequent attempts have failed. The immune mechanisms involved can differ between the two, and the investigation is tailored accordingly.

6. Is there a waiting period to get an online consultation at ICPRM?

Consultation availability varies and is best confirmed directly with ICPRM. Because the initial consultation is online, geographical distance does not add to the wait time, and the process can typically begin within a reasonable timeframe after the consultation is booked.

7. Are the investigation tests for ImmuLIT candidacy available across India?

Many of the immune tests recommended by ICPRM are available at accredited diagnostic laboratories in major Indian cities. For patients in areas with limited diagnostic access, ICPRM advises on the most practical options for completing the required investigations without requiring travel to the centre.